News Agency
Men's Weekly

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250 Million

  • Written by PR Newswire
  • Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol)
  • Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care's commercial platform to grow Movantik volume in the U.S. while reducing gross-to-net and operating costs
  • First quarter financial highlights...

Read more: Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of Approximately $250...

How Signage Shapes Business Visibility And Customer Perception

In today’s competitive commercial environment, signage is far more than just a display element—it acts as a silent communicator between a business and its audience. Whether positioned outdoors or within a retail or corporate space, it provides immediate information about what... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion